Otsuka Pharmaceutical Co., Ltd. v. JAMP Pharma Corporation

Call to arrange a consultation

2023

T-1730-23

Resovled

6(1) PMNOC

Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,602,247 (brexpiprazole).

Counsel to:

JAMP Pharma Corporation

The decision is reported

Partner

Counsel

Associate